Vilon Research: What the Peptide Bioregulator Literature…

For laboratory and research use only. Not for human consumption.

Vilon is a short synthetic dipeptide studied within the "peptide bioregulator" research tradition, a body of literature originating with the work of Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. This overview covers how published research describes Vilon's studied mechanism and the research context in which it appears, alongside its relationship to Epitalon, the more widely cited compound from the same research lineage.

Key facts: Vilon is a synthetic dipeptide composed of the amino acids lysine and glutamic acid (Lys-Glu), studied in the peptide bioregulator research literature associated with thymic tissue and immune-cell-related research models. It belongs to the same Khavinson-school research tradition as Epitalon, though the two compounds are studied in connection with different tissue systems — Vilon with thymic/immune research contexts and Epitalon with pineal-gland-associated research. Vilon is available from Optimized Aminos strictly for laboratory and research use.

What Vilon Is in the Research Literature

Vilon is classified in published research as a short synthetic peptide bioregulator, structurally represented as the dipeptide Lys-Glu (lysine-glutamic acid). It was developed and characterized within a research program examining whether very short peptide sequences derived from or modeled on tissue extracts could be synthesized and studied for tissue-specific research effects. This program produced a family of short peptides — Vilon among them — each associated in the literature with a particular organ or tissue system used as the basis for its research model.

Mechanism Described in Published Studies

Proposed Gene-Regulatory Activity

The peptide bioregulator research framework, as described in the literature associated with this compound class, proposes that very short peptides such as Vilon can interact with chromatin and influence the transcriptional activity of specific gene clusters relevant to the tissue type under study. In the case of Vilon, published research describes this proposed activity in connection with thymic tissue and immune-cell-related research models, distinguishing it from longer, receptor-mediated peptides such as growth-hormone secretagogues.

Research Models Referenced in the Literature

Published Vilon research has generally involved laboratory and animal models designed to examine markers associated with thymic tissue function and immune-cell population dynamics. As with all compounds discussed on this site, this summary describes what the published literature reports about study models — it does not describe or imply any outcome in humans.

Connection to Epitalon and the Broader Bioregulator Research Lineage

Vilon is frequently discussed alongside Epitalon (Ala-Glu-Asp-Gly) because both compounds emerged from the same Khavinson-school peptide bioregulator research program and share the proposed chromatin-interaction mechanism described above. The key distinction researchers draw between the two is tissue association: Epitalon is studied primarily in connection with pineal-gland-associated research models, while Vilon is studied in connection with thymic and immune-related research models. For a deeper look at the better-documented compound in this pair, see our Epitalon research literature overview, which covers the broader bioregulator research framework in more detail and provides useful background for interpreting Vilon's place within the same tradition.

Terminology and Research Documentation

Because peptide bioregulator terminology (chromatin interaction, tissue-specific gene expression, short-peptide nomenclature) can be unfamiliar outside this specific research niche, our 150-term peptide chemistry glossary is a useful reference for researchers encountering these concepts for the first time. For background on how short synthetic peptides like Vilon are manufactured, see our overview of solid-phase peptide synthesis, and for the current regulatory framing applicable to RUO compounds in this category, see are research peptides legal in 2026?

Why Vilon Is Studied Alongside Immune-Related Research Markers

The thymus is the tissue most closely associated with the maturation of T-cell populations in immunology research, and its function is frequently reported in the literature to decline with age in the animal models studied. This is the research backdrop against which Vilon's proposed mechanism has typically been examined — not as a general "immune support" concept, but as a narrower question of whether a short peptide bioregulator can influence measurable markers of thymic tissue activity within a defined study model. Researchers designing protocols in this space often pair Vilon alongside other short bioregulator peptides to compare tissue-specific effects across multiple organ systems in the same experimental design, which is one reason the compound tends to appear in review literature alongside Epitalon and Thymalin rather than in isolation.

Handling and Sourcing Considerations

Vilon is supplied as a lyophilized powder for laboratory use. Researchers preparing solutions for documentation purposes can use our reconstitution calculator to compute the resulting concentration (mg/mL) from a given vial mass and diluent volume for laboratory records. As with any short peptide bioregulator, identity and purity should be confirmed against a batch-specific Certificate of Analysis before use in a study protocol — see our testing page for the third-party methods applied across our catalog. Researchers cataloging bioregulator peptides alongside other longevity- and cellular-research-adjacent compounds may also find our NAD+ listing a useful comparative reference point within that broader research category.

Frequently Asked Questions

What is Vilon studied for in the research literature?

Vilon is studied in the peptide bioregulator research literature in connection with thymic tissue and immune-cell-related research models. Published research describes a proposed mechanism involving interaction with chromatin and influence on tissue-specific gene transcription.

How is Vilon related to Epitalon?

Vilon and Epitalon both originate from the same Khavinson-school peptide bioregulator research program and share a proposed chromatin-interaction mechanism. They are studied in connection with different tissue systems: Vilon with thymic and immune research models, and Epitalon with pineal-gland-associated research.

What is Vilon's chemical structure?

Vilon is a synthetic dipeptide composed of the amino acids lysine and glutamic acid, represented in the literature as Lys-Glu.

Is Vilon research conducted in humans?

This overview describes what published laboratory and animal-model research reports about Vilon's studied mechanism. It makes no claims about outcomes in humans and is intended strictly for research and educational purposes.

How should Vilon be documented for a laboratory record?

Researchers typically reconstitute Vilon's lyophilized powder to a specific concentration for documentation purposes, calculated in mg/mL, and confirm identity and purity against a batch-specific Certificate of Analysis before logging it into a study.